Prognostic significance of Ki67 (MIB1) proliferation index and p53 over-expression in chondrosarcomas

International Journal of Cancer

Volumn 69, Issue 2, 1996, Pages 86-91

  Nawa, Gen ^a   Ueda, Takafumi ^a   Mori, Shigeki ^a   Yoshikawa, Hideki ^a   Fukuda, Haruki ^b   Ishiguro, Shingo ^a   Funai, Hiroko ^a   Uchida, Atsumasa ^b  

^a CENTER FOR ADULT DISEASES   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CHILD; CHONDROSARCOMA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CELL DIVISION; CHILD; CHONDROSARCOMA; FEMALE; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030002608     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960422)69:2<86::AID-IJC3>3.0.CO;2-R     Document Type: Article

References (26)

1. CAMPO, E., CALLE-MARTIN, O., MIQUEL, R., PALACIN, A., ROMERO, M., FABREGAT, V., VIVES, J., CARDESA, A. and YAGUE, J., Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res., 51, 4436-4442 (1991).
2. CATTORETTI, G., BECKER, M.H., KEY, G., DUCHROW, M., SCHLUTER, C., GALLE, J. and GERDES, J., Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol., 168, 357-363 (1992).
3. CATTORETTI, G., RILKE, F., ANDREOLA, S., D'AMATO, L. and DELIA, D., p53 expression in breast cancer. Int. J. Cancer, 41, 178-183 (1988).
4. DOBASHI, Y., SUGIMURA, H., SATO, A., HIRABAYASHI, T., KANDA, H., KITAGAWA, T., KAWAGUCHI, N., IMAMURA, T. and MACHINAMI, R., Possible association of p53 over-expression and mutation with highgrade chondrosarcoma. Diagn. mol. Pathol., 2, 257-263 (1993).
5. DROBNJAK, M., LATRES, E., POLLACK, D., KARPEH, M., DUDAS, M., WOODRUFF, J.M., BRENNAN, M.F. and CORDON-CARDO, C., Prognostic implications of p53 nuclear over-expression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J. nat. Cancer Iast., 86, 549-554 (1994).
6. EVANS, H.L., AYALA, A.G. and ROMSDAHL, M.M., Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer, 40, 818-831 (1977).
7. FIELDS, S. and JANG. S.K., Presence of a potent transcription-activating sequence in the p53 protein, Science, 249, 1046-1049 (1990).
8. FINLAY, C.A., HINDS, P.W., TAN T.H., ELIYAHU. D., OREN, M. and LEVINE, A.J., Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. cell. Biol., 8, 531-539 (1988).
9. GERDES, J., LELLE, R.J., PICKARTZ, H., HEIDENREICH, W., SCHWARIING, R., KURTSIEFER, L., STAUCH, G. and STEIN H., Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J clin Pathol., 39, 977-980 (1986).
10. HALL. P.A., RICHARDS, M.A., GREGORY, W.M., D'ARDEKNE, A J. LISTER, T.A. and STANSFELD, A.G , The prognostic value of K167 immunostaming in non-Hodskin's lymphoma. J. Pathol., 154, 223-235 (1988).
11. HUVOS, A.G., Bone tumors: diagnosis, treatment and prognosis (2nd ed.), pp. 343-381. W.B. Saunders, Philadelphia (1991).
12. JAROS, E., PERRY, R.H., ADAM, L., KELLY, P.J., CRAWFORD, P J. KALBAG, R.M., MENDELOW, A.D., SENGUPTA, R.P. and PEARSON. A.D., Prognostic implications of p53 protein, epidermal-growth-factor receptor, and Ki-67 labelling in brain tumours. Brit. J. Cancer, 66. 373-385 (1992).
13. KREICBERGS, A., BOQUIST, L., BORSSEN, B. and LARSSON, S.E., Prognostic factors in chondrosarcoma: a comparative study of cellular DNA content and clinicopathologic features. Cancer, 50, 577-583 (1982).
14. MASUDA, H., MILLER, C., KOEFFLER, H.P., BATTIFORA, H. and CLINE, M.J., Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. nat. Acad. Sci. (Wash.), 84, 7716-7719 (1987).
15. MCCORMICK, D., CHONG, H., HOBBS, C., DATTA, C. and HALL, P.A., Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology. 22, 355-360 (1993).
16. MIRRA, J.M., GOLD, R., DOWNS, J, and ECKARDT, J.J., A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases. Clin. Orthop.. 201, 214-237 (1985).
17. MORKVE, O., HALVORSEN, O.J., STANGELAND, L., GULSVIK, A. and LAERUM, O.D., Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell lung cancer. Int. J. Cancer, 52, 851-855 (1992).
18. MURATA, H., KUSUZAKI, K., TAKESHITA, H., FUKUMOTO, K., NAKAMURA, S., HIRASAWA, Y. and ASHIHARA, T., DNA ploidy analysis of chondrosarcoma in associated with histological grade and biological malignancy. 8th International Symposium on Limb Salvage (ISOLS) (Abstract), p. 168, Florence (1995).
19. QUINN, C.M. and WRIGHT, N. A., The clinical assessment of proliferation and growth in human tumors: evaluation of methods and applications as prognostic variables.J. Pathol, 160, 93-102 (1990).
20. SCOTLANDI, K., SERRA, M., MANARA, M.C., MAURICI, D., BENINI, S., NINI, G., CAMPANACCI, M. and BALDINI, N., Clinical relevance of Ki-67 expression in bone tumors. Cancer, 75, 806-814 (1995).
21. SOOMRO, I.N. and WHIMSTER, W.F., Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with AgNOR scores. J. Pathol., 162, 217-222 (1990).
22. TOGUCHIDA, J., YAMAGUCHI, T., RITCHIE, B., BEAUCHAMP, R.L., DAYTON. S.H., HERRERA, G.E., YAMAMURO, T., KOTOURA, Y., SASAKI, M.S. and LITTLE, J.B., Mutation spectrum of the p53 gene in bone and soft-tissue sarcomas. Cancer Res., 52, 6194-6199 (1992).
23. UEDA, T., AOZASA, K., TSUJIMOTO, M., OHSAWA, M., UCHIDA, A., AOKI, Y., ONO, K. and MATSUMOTO, K., Prognostic significance of Ki-67 reactivity in soft-tissue sarcomas. Cancer, 63, 1607-1611 (1989).
24. VOLLMER, E., ROESSNER, A., GERDES, J., MELLIN, W., STEIN, H., CHONG, H., SCHACHEL, S. and GRUNDMANN, E., Improved grading of bone tumors with the monoclonal antibody Ki-67. J. Cancer Res. clin. OncoL, 112, 281-282 (1986).
25. WADAYAMA, B., TOGUCHIDA, J., YAMAGUCHI, T., SASAKI, M.S., KoTOURA, Y. and YAMAMURO, T., p53 expression and its relationship to DNA alterations in bone and soft-tissue sarcomas. Brit. J. Cancer, 68, 1134-1139 (1993).
26. ZUBER. P., HAMOU, M.F. and DETRIBOLET, N., Identification of proliferating cells in human ghomas using the monoclonal antibody Ki-67. Neurosurgery, 22, 364-368 (1988).